B
RDHL

Bridgeworth’s Redhill Biopharma RDHL Stock Holding History

Bridgeworth’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1
Closed -$8K – 440
2018
Q2 		$8K Buy
+1
New +$6.36K ﹤0.01% 464

Other funds holding RDHL

6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MC
Menta Capital San Francisco, California $236M AUM 6.6% 1-Year Est. Return

Bridgeworth's RDHL Position: Q3 2018 in Review

Bridgeworth sold out of Redhill Biopharma (RDHL) in Q3 2018, closing a stake of 1 share — an estimated $8K sold.

Bridgeworth first reported a position in RDHL in Q2 2018 and held it in 1 quarter. The position peaked at $8K in Q2 2018. 38 funds tracked by Wall St. Rank hold RDHL as of Q3 2018.

  • Bridgeworth reported no remaining Redhill Biopharma position as of Q3 2018 after selling out during the quarter.
  • Bridgeworth sold 1 Redhill Biopharma share in Q3 2018, an estimated $8K.
  • Bridgeworth first reported a position in Redhill Biopharma in Q2 2018 and held it in 1 quarter.
  • Bridgeworth's Redhill Biopharma position peaked at $8K in Q2 2018.
  • 38 funds tracked by Wall St. Rank held Redhill Biopharma as of Q3 2018.

Based on Bridgeworth's 13F filing for Q3 2018, filed 13 Nov 2018.